

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to type I interferon (GO:0071357) | 6.00684645 |
| 2 | type I interferon signaling pathway (GO:0060337) | 6.00684645 |
| 3 | response to type I interferon (GO:0034340) | 5.92567181 |
| 4 | regulation of chronic inflammatory response (GO:0002676) | 5.65954518 |
| 5 | positive regulation of interferon-alpha production (GO:0032727) | 5.57101011 |
| 6 | response to interferon-alpha (GO:0035455) | 5.30578227 |
| 7 | regulation of interferon-alpha production (GO:0032647) | 5.25120253 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.20395508 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.20395508 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.20395508 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 5.20395508 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 5.20395508 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.20395508 |
| 14 | negative regulation of viral genome replication (GO:0045071) | 5.17950512 |
| 15 | cellular response to interferon-alpha (GO:0035457) | 5.15791347 |
| 16 | cellular response to exogenous dsRNA (GO:0071360) | 4.90237503 |
| 17 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.84648673 |
| 18 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.74705175 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.65799912 |
| 20 | regulation of type 2 immune response (GO:0002828) | 4.57883284 |
| 21 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.54146896 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 4.37003049 |
| 23 | positive regulation of antigen processing and presentation (GO:0002579) | 4.31708924 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.28565239 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.28565239 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.25773038 |
| 27 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.23405814 |
| 28 | response to peptidoglycan (GO:0032494) | 4.20333620 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.19631910 |
| 30 | response to host immune response (GO:0052572) | 4.19631910 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.17895126 |
| 32 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.14938712 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 4.13521328 |
| 34 | positive regulation of type 2 immune response (GO:0002830) | 4.08732251 |
| 35 | natural killer cell activation involved in immune response (GO:0002323) | 3.98102436 |
| 36 | T-helper 1 type immune response (GO:0042088) | 3.97932802 |
| 37 | kynurenine metabolic process (GO:0070189) | 3.95898466 |
| 38 | * positive regulation of cAMP-mediated signaling (GO:0043950) | 3.89290592 |
| 39 | cellular response to virus (GO:0098586) | 3.88223616 |
| 40 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.87376282 |
| 41 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.86080650 |
| 42 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.84951841 |
| 43 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.84168183 |
| 44 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.84168183 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 3.83183621 |
| 46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.80328640 |
| 47 | positive regulation of defense response to virus by host (GO:0002230) | 3.78389264 |
| 48 | positive regulation of interferon-beta production (GO:0032728) | 3.78293837 |
| 49 | regulation of interleukin-12 production (GO:0032655) | 3.75422413 |
| 50 | regulation of T-helper cell differentiation (GO:0045622) | 3.75245709 |
| 51 | tryptophan catabolic process (GO:0006569) | 3.74909188 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 3.74909188 |
| 53 | indolalkylamine catabolic process (GO:0046218) | 3.74909188 |
| 54 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.73149340 |
| 55 | response to host (GO:0075136) | 3.69107198 |
| 56 | response to host defenses (GO:0052200) | 3.69107198 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.69107198 |
| 58 | neutrophil activation involved in immune response (GO:0002283) | 3.66594989 |
| 59 | regulation of tolerance induction (GO:0002643) | 3.64224442 |
| 60 | regulation of vitamin metabolic process (GO:0030656) | 3.64071932 |
| 61 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.63019815 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.60735575 |
| 63 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.60063827 |
| 64 | positive regulation of tolerance induction (GO:0002645) | 3.59563065 |
| 65 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.55015098 |
| 66 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.54807632 |
| 67 | superoxide anion generation (GO:0042554) | 3.51931284 |
| 68 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.50835099 |
| 69 | defense response to virus (GO:0051607) | 3.49089896 |
| 70 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.47149575 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 3.46917558 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.46563119 |
| 73 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.45049170 |
| 74 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.43943231 |
| 75 | response to interferon-beta (GO:0035456) | 3.43470636 |
| 76 | regulation of activation of Janus kinase activity (GO:0010533) | 3.42827149 |
| 77 | * lymphocyte chemotaxis (GO:0048247) | 3.41797771 |
| 78 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.40142078 |
| 79 | reactive oxygen species biosynthetic process (GO:1903409) | 3.39890802 |
| 80 | regulation of RIG-I signaling pathway (GO:0039535) | 3.38088384 |
| 81 | macrophage activation involved in immune response (GO:0002281) | 3.37852234 |
| 82 | negative regulation of T cell mediated immunity (GO:0002710) | 3.35524364 |
| 83 | positive regulation of heat generation (GO:0031652) | 3.35007234 |
| 84 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.34731640 |
| 85 | detection of molecule of bacterial origin (GO:0032490) | 3.34649424 |
| 86 | microglial cell activation (GO:0001774) | 3.32509974 |
| 87 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.31373073 |
| 88 | dendritic cell differentiation (GO:0097028) | 3.30055081 |
| 89 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.29323608 |
| 90 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.28189420 |
| 91 | natural killer cell mediated immunity (GO:0002228) | 3.28189420 |
| 92 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.26559631 |
| 93 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.26159264 |
| 94 | regulation of response to interferon-gamma (GO:0060330) | 3.25916265 |
| 95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.25619157 |
| 96 | interferon-gamma secretion (GO:0072643) | 3.24330774 |
| 97 | cellular response to interferon-gamma (GO:0071346) | 3.24312145 |
| 98 | positive regulation of interleukin-17 production (GO:0032740) | 3.23362016 |
| 99 | defense response to protozoan (GO:0042832) | 3.22086879 |
| 100 | negative regulation of interleukin-10 production (GO:0032693) | 3.21576010 |
| 101 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.21141695 |
| 102 | regulation of fever generation (GO:0031620) | 3.20930286 |
| 103 | response to interferon-gamma (GO:0034341) | 3.20461328 |
| 104 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.20456910 |
| 105 | cellular response to lipopolysaccharide (GO:0071222) | 3.20046862 |
| 106 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.13996722 |
| 107 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.11858411 |
| 108 | cellular response to interferon-beta (GO:0035458) | 3.11275431 |
| 109 | cellular response to molecule of bacterial origin (GO:0071219) | 3.11136553 |
| 110 | respiratory burst (GO:0045730) | 3.10922546 |
| 111 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.10266243 |
| 112 | negative regulation of type I interferon production (GO:0032480) | 3.09603312 |
| 113 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.07988562 |
| 114 | NAD biosynthetic process (GO:0009435) | 3.06733083 |
| 115 | regulation of T-helper 1 type immune response (GO:0002825) | 3.06438219 |
| 116 | JAK-STAT cascade (GO:0007259) | 3.05892682 |
| 117 | B cell mediated immunity (GO:0019724) | 3.05659717 |
| 118 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.05627286 |
| 119 | myeloid dendritic cell activation (GO:0001773) | 3.04901535 |
| 120 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.04724017 |
| 121 | positive regulation of interleukin-12 production (GO:0032735) | 3.04488290 |
| 122 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.03544797 |
| 123 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.03166645 |
| 124 | regulation of mononuclear cell migration (GO:0071675) | 3.01975209 |
| 125 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.01419227 |
| 126 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.01117493 |
| 127 | granulocyte activation (GO:0036230) | 2.99890356 |
| 128 | regulation of podosome assembly (GO:0071801) | 2.99552588 |
| 129 | myeloid dendritic cell differentiation (GO:0043011) | 2.99525090 |
| 130 | response to protozoan (GO:0001562) | 2.99212924 |
| 131 | regulation of defense response to virus by host (GO:0050691) | 2.95715737 |
| 132 | neutrophil activation (GO:0042119) | 2.94153228 |
| 133 | positive regulation of T cell cytokine production (GO:0002726) | 2.89670369 |
| 134 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.88757586 |
| 135 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.88490959 |
| 136 | regulation of viral genome replication (GO:0045069) | 2.86409818 |
| 137 | intracellular pH reduction (GO:0051452) | 2.79971950 |
| 138 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.79025854 |
| 139 | negative regulation of viral process (GO:0048525) | 2.78536187 |
| 140 | response to muramyl dipeptide (GO:0032495) | 2.78385166 |
| 141 | detection of external biotic stimulus (GO:0098581) | 2.77852212 |
| 142 | regulation of heat generation (GO:0031650) | 2.71907705 |
| 143 | detection of other organism (GO:0098543) | 2.71274696 |
| 144 | macrophage activation (GO:0042116) | 2.70292705 |
| 145 | regulation of interferon-beta production (GO:0032648) | 2.69816757 |
| 146 | detection of bacterium (GO:0016045) | 2.69581240 |
| 147 | positive regulation of T cell migration (GO:2000406) | 2.68083737 |
| 148 | arginine catabolic process (GO:0006527) | 2.66334179 |
| 149 | * T cell migration (GO:0072678) | 2.65278972 |
| 150 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.64470659 |
| 151 | response to exogenous dsRNA (GO:0043330) | 2.63661071 |
| 152 | positive regulation of lymphocyte migration (GO:2000403) | 2.62871731 |
| 153 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.60695635 |
| 154 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.60695635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.63414916 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 7.39452521 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.56298949 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.01902355 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.81334223 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.45472581 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.30110529 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.21827327 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91760403 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.88496553 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.86711038 |
| 12 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.70624365 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63444770 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53610376 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.40543583 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.37550894 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.31796928 |
| 18 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20757091 |
| 19 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11672491 |
| 20 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.08021211 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05844260 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.01879782 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00188971 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97725595 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77120200 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.71072245 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70172875 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67039467 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63981391 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62736803 |
| 31 | * MYB_26560356_Chip-Seq_TH2_Human | 1.46060629 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42584011 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42142532 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.36621639 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33214720 |
| 36 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.32331278 |
| 37 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29144538 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28610332 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22734714 |
| 40 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21468805 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20633351 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.20382502 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19827995 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19226620 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19107880 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18724470 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17482187 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17171524 |
| 49 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14707255 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14619461 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.11900014 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11312597 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10917578 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02146714 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02146714 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01114508 |
| 57 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98635552 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97807352 |
| 59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96179054 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95504233 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95347568 |
| 62 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95260825 |
| 63 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94751195 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93607241 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93022112 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90167676 |
| 67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88300088 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88190277 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86453680 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85787663 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85538464 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84957979 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84847840 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83879845 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83784297 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82816354 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82308660 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81995709 |
| 79 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.81808878 |
| 80 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.81808878 |
| 81 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.81808878 |
| 82 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.81278633 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80887344 |
| 84 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.80817875 |
| 85 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80560227 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79575799 |
| 87 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.78792233 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.78438234 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77727796 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76684563 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76042401 |
| 92 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.75842788 |
| 93 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75769744 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 0.75641582 |
| 95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75568003 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.75072664 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74424055 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73845460 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73723338 |
| 100 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73479206 |
| 101 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.72567128 |
| 102 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72327106 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72290507 |
| 104 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.71236585 |
| 105 | UTX_26944678_Chip-Seq_JUKART_Human | 0.70987751 |
| 106 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70814919 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70648765 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70519820 |
| 109 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70130391 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68824886 |
| 111 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.68788140 |
| 112 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68751689 |
| 113 | P300_19829295_ChIP-Seq_ESCs_Human | 0.68734431 |
| 114 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68588838 |
| 115 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.68204000 |
| 116 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.67769618 |
| 117 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67184137 |
| 118 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.67180511 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66786497 |
| 120 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.66534943 |
| 121 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.66375901 |
| 122 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.66267744 |
| 123 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66261362 |
| 124 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.66260273 |
| 125 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.66157382 |
| 126 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.65925005 |
| 127 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.65116327 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64974940 |
| 129 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.64799753 |
| 130 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.64524426 |
| 131 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.64466803 |
| 132 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.64107133 |
| 133 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.63245159 |
| 134 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.62457332 |
| 135 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.62069844 |
| 136 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.61897420 |
| 137 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.61758229 |
| 138 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.61587698 |
| 139 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.59685253 |
| 140 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59298039 |
| 141 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.56823932 |
| 142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54935905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.35060250 |
| 2 | MP0009785_altered_susceptibility_to | 3.88774101 |
| 3 | MP0006082_CNS_inflammation | 3.40347434 |
| 4 | MP0003724_increased_susceptibility_to | 3.37912776 |
| 5 | MP0004510_myositis | 3.28633219 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.12662429 |
| 7 | MP0003436_decreased_susceptibility_to | 3.10202048 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.00455035 |
| 9 | MP0000685_abnormal_immune_system | 2.95087871 |
| 10 | MP0005387_immune_system_phenotype | 2.89546559 |
| 11 | MP0001790_abnormal_immune_system | 2.89546559 |
| 12 | MP0005025_abnormal_response_to | 2.88062512 |
| 13 | MP0005671_abnormal_response_to | 2.64043975 |
| 14 | MP0002419_abnormal_innate_immunity | 2.63175723 |
| 15 | MP0005360_urolithiasis | 2.55344175 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.52940894 |
| 17 | MP0009764_decreased_sensitivity_to | 2.49938471 |
| 18 | MP0002254_reproductive_system_inflammat | 2.32935913 |
| 19 | MP0001800_abnormal_humoral_immune | 2.32436616 |
| 20 | MP0003303_peritoneal_inflammation | 2.20691035 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.14940498 |
| 22 | MP0002723_abnormal_immune_serum | 2.14424277 |
| 23 | MP0004782_abnormal_surfactant_physiolog | 2.02485376 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.97862006 |
| 25 | MP0009840_abnormal_foam_cell | 1.96908510 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.95390634 |
| 27 | MP0002277_abnormal_respiratory_mucosa | 1.85952560 |
| 28 | MP0001853_heart_inflammation | 1.85803028 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.83979667 |
| 30 | MP0005365_abnormal_bile_salt | 1.82984939 |
| 31 | MP0008469_abnormal_protein_level | 1.82796512 |
| 32 | MP0001819_abnormal_immune_cell | 1.74063855 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.71928765 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.70055149 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.68941174 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.67362949 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.67150779 |
| 38 | MP0004947_skin_inflammation | 1.67021826 |
| 39 | MP0004858_abnormal_nervous_system | 1.60794017 |
| 40 | MP0003075_altered_response_to | 1.59735330 |
| 41 | MP0003195_calcinosis | 1.56377639 |
| 42 | MP0005310_abnormal_salivary_gland | 1.54709633 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.51209495 |
| 44 | MP0003186_abnormal_redox_activity | 1.49742909 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.43465105 |
| 46 | MP0003448_altered_tumor_morphology | 1.42309101 |
| 47 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41127780 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.36149732 |
| 49 | MP0006054_spinal_hemorrhage | 1.34604535 |
| 50 | MP0000604_amyloidosis | 1.31631120 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.29274535 |
| 52 | MP0005083_abnormal_biliary_tract | 1.28952122 |
| 53 | MP0000343_altered_response_to | 1.26755505 |
| 54 | MP0009763_increased_sensitivity_to | 1.19165511 |
| 55 | MP0009278_abnormal_bone_marrow | 1.18544116 |
| 56 | MP0001764_abnormal_homeostasis | 1.15966850 |
| 57 | MP0010329_abnormal_lipoprotein_level | 1.14484395 |
| 58 | MP0000716_abnormal_immune_system | 1.14378607 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.12948248 |
| 60 | MP0003252_abnormal_bile_duct | 1.10721945 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.10704871 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.09180043 |
| 63 | MP0005451_abnormal_body_composition | 1.08493174 |
| 64 | MP0005332_abnormal_amino_acid | 1.08410410 |
| 65 | MP0003646_muscle_fatigue | 1.08085392 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.07743428 |
| 67 | MP0005164_abnormal_response_to | 1.06726659 |
| 68 | MP0005171_absent_coat_pigmentation | 1.03998872 |
| 69 | MP0003690_abnormal_glial_cell | 1.03629250 |
| 70 | MP0000609_abnormal_liver_physiology | 1.02974113 |
| 71 | MP0001346_abnormal_lacrimal_gland | 1.00559435 |
| 72 | MP0000920_abnormal_myelination | 0.96885584 |
| 73 | MP0003183_abnormal_peptide_metabolism | 0.95508219 |
| 74 | MP0002006_tumorigenesis | 0.94332961 |
| 75 | MP0009697_abnormal_copulation | 0.93843661 |
| 76 | MP0002405_respiratory_system_inflammati | 0.93472588 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93161971 |
| 78 | MP0008260_abnormal_autophagy | 0.92461542 |
| 79 | MP0005166_decreased_susceptibility_to | 0.90270033 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.89862820 |
| 81 | MP0002398_abnormal_bone_marrow | 0.89840424 |
| 82 | MP0003763_abnormal_thymus_physiology | 0.88916782 |
| 83 | MP0003091_abnormal_cell_migration | 0.88835817 |
| 84 | MP0003011_delayed_dark_adaptation | 0.88654391 |
| 85 | MP0005248_abnormal_Harderian_gland | 0.86733677 |
| 86 | MP0005390_skeleton_phenotype | 0.86264034 |
| 87 | MP0002429_abnormal_blood_cell | 0.84157651 |
| 88 | MP0002722_abnormal_immune_system | 0.84000827 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83862383 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 0.83622406 |
| 91 | MP0002166_altered_tumor_susceptibility | 0.83393870 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.80246523 |
| 93 | MP0005647_abnormal_sex_gland | 0.75838194 |
| 94 | MP0000858_altered_metastatic_potential | 0.74923262 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.74317775 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.74309700 |
| 97 | MP0008004_abnormal_stomach_pH | 0.74296596 |
| 98 | MP0008874_decreased_physiological_sensi | 0.73161243 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.72393055 |
| 100 | MP0005645_abnormal_hypothalamus_physiol | 0.71954119 |
| 101 | MP0004883_abnormal_blood_vessel | 0.71544779 |
| 102 | MP0001542_abnormal_bone_strength | 0.71492652 |
| 103 | MP0005165_increased_susceptibility_to | 0.70994818 |
| 104 | MP0001881_abnormal_mammary_gland | 0.70994070 |
| 105 | MP0001663_abnormal_digestive_system | 0.69208651 |
| 106 | MP0003300_gastrointestinal_ulcer | 0.69032402 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.68982737 |
| 108 | MP0004808_abnormal_hematopoietic_stem | 0.68732770 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.68642022 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.68223421 |
| 111 | MP0001873_stomach_inflammation | 0.67026582 |
| 112 | MP0000372_irregular_coat_pigmentation | 0.66391352 |
| 113 | MP0000689_abnormal_spleen_morphology | 0.65139035 |
| 114 | MP0002090_abnormal_vision | 0.64292668 |
| 115 | MP0001545_abnormal_hematopoietic_system | 0.63792368 |
| 116 | MP0005397_hematopoietic_system_phenotyp | 0.63792368 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.62605957 |
| 118 | MP0005266_abnormal_metabolism | 0.60543844 |
| 119 | MP0005535_abnormal_body_temperature | 0.60291764 |
| 120 | MP0001348_abnormal_lacrimal_gland | 0.59435994 |
| 121 | MP0002163_abnormal_gland_morphology | 0.58784411 |
| 122 | MP0002933_joint_inflammation | 0.54184789 |
| 123 | MP0002877_abnormal_melanocyte_morpholog | 0.54124153 |
| 124 | MP0000249_abnormal_blood_vessel | 0.53628967 |
| 125 | MP0002693_abnormal_pancreas_physiology | 0.52676685 |
| 126 | MP0005023_abnormal_wound_healing | 0.52063351 |
| 127 | MP0003795_abnormal_bone_structure | 0.51037779 |
| 128 | MP0005666_abnormal_adipose_tissue | 0.50522208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.44998101 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.29397820 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.18216101 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.14869223 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.43879794 |
| 6 | Tetraparesis (HP:0002273) | 4.37823001 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.35288227 |
| 8 | Increased IgM level (HP:0003496) | 4.26938582 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.98272996 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.92113197 |
| 11 | Hemoptysis (HP:0002105) | 3.82237946 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.76536353 |
| 13 | Chronic otitis media (HP:0000389) | 3.73378541 |
| 14 | Basal ganglia calcification (HP:0002135) | 3.69650115 |
| 15 | Gingivitis (HP:0000230) | 3.69181082 |
| 16 | Orchitis (HP:0100796) | 3.59295761 |
| 17 | Recurrent skin infections (HP:0001581) | 3.54713279 |
| 18 | Gangrene (HP:0100758) | 3.51235902 |
| 19 | Myositis (HP:0100614) | 3.47137955 |
| 20 | Optic neuritis (HP:0100653) | 3.43306820 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.43306820 |
| 22 | Prostate neoplasm (HP:0100787) | 3.34424321 |
| 23 | Disinhibition (HP:0000734) | 3.31665619 |
| 24 | Hematochezia (HP:0002573) | 3.29870521 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.23235852 |
| 26 | Vasculitis (HP:0002633) | 3.22983655 |
| 27 | Stomatitis (HP:0010280) | 3.17257028 |
| 28 | Joint hemorrhage (HP:0005261) | 3.14570347 |
| 29 | T lymphocytopenia (HP:0005403) | 3.08333420 |
| 30 | Premature loss of primary teeth (HP:0006323) | 3.08091319 |
| 31 | Abnormality of T cell number (HP:0011839) | 3.07362836 |
| 32 | Abnormality of proline metabolism (HP:0010907) | 2.97918204 |
| 33 | Hydroxyprolinuria (HP:0003080) | 2.97918204 |
| 34 | Hypergammaglobulinemia (HP:0010702) | 2.97719668 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.91885633 |
| 36 | Prolonged neonatal jaundice (HP:0006579) | 2.91712996 |
| 37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.87256298 |
| 38 | Gingival bleeding (HP:0000225) | 2.83336703 |
| 39 | Urticaria (HP:0001025) | 2.82187617 |
| 40 | Intrahepatic cholestasis (HP:0001406) | 2.81730318 |
| 41 | Parakeratosis (HP:0001036) | 2.81106236 |
| 42 | Periodontitis (HP:0000704) | 2.80096097 |
| 43 | Prolonged partial thromboplastin time (HP:0003645) | 2.78372886 |
| 44 | Xanthomatosis (HP:0000991) | 2.77271586 |
| 45 | Encephalitis (HP:0002383) | 2.68744518 |
| 46 | Myocardial infarction (HP:0001658) | 2.68376568 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.67770347 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.67770347 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.64854557 |
| 50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.64146510 |
| 51 | Recurrent viral infections (HP:0004429) | 2.60194344 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.58132157 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.57902022 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.57902022 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.57902022 |
| 56 | Abnormality of the endocardium (HP:0004306) | 2.56434852 |
| 57 | Complement deficiency (HP:0004431) | 2.52902261 |
| 58 | Hyperlipoproteinemia (HP:0010980) | 2.51005774 |
| 59 | Glomerulonephritis (HP:0000099) | 2.50691641 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.49436310 |
| 61 | Progressive neurologic deterioration (HP:0002344) | 2.47630233 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.47379770 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47379770 |
| 64 | Mutism (HP:0002300) | 2.46437758 |
| 65 | Recurrent pneumonia (HP:0006532) | 2.44695989 |
| 66 | Vacuolated lymphocytes (HP:0001922) | 2.44524103 |
| 67 | Pustule (HP:0200039) | 2.43711109 |
| 68 | Obstructive lung disease (HP:0006536) | 2.43295597 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43295597 |
| 70 | Polyneuropathy (HP:0001271) | 2.41915127 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.40376998 |
| 72 | Joint swelling (HP:0001386) | 2.40056773 |
| 73 | Chronic sinusitis (HP:0011109) | 2.37472014 |
| 74 | Epidermoid cyst (HP:0200040) | 2.37266563 |
| 75 | Thick nail (HP:0001805) | 2.36412427 |
| 76 | Pulmonary embolism (HP:0002204) | 2.35544711 |
| 77 | Vertigo (HP:0002321) | 2.35141092 |
| 78 | Nuclear cataract (HP:0100018) | 2.34705756 |
| 79 | Mitral stenosis (HP:0001718) | 2.34333211 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.32188722 |
| 81 | Lower limb hyperreflexia (HP:0002395) | 2.31971940 |
| 82 | B lymphocytopenia (HP:0010976) | 2.31187240 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 2.30894147 |
| 84 | Keratoconjunctivitis (HP:0001096) | 2.30222070 |
| 85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30001598 |
| 86 | Anorexia (HP:0002039) | 2.29597443 |
| 87 | Abnormality of the pericardium (HP:0001697) | 2.27727896 |
| 88 | Colitis (HP:0002583) | 2.26257634 |
| 89 | Malnutrition (HP:0004395) | 2.25873507 |
| 90 | Axonal loss (HP:0003447) | 2.24912422 |
| 91 | Increased serum ferritin (HP:0003281) | 2.23821756 |
| 92 | Conjugated hyperbilirubinemia (HP:0002908) | 2.23034423 |
| 93 | Recurrent bronchitis (HP:0002837) | 2.22998758 |
| 94 | Arterial thrombosis (HP:0004420) | 2.21852442 |
| 95 | Nephritis (HP:0000123) | 2.20938711 |
| 96 | Neurofibrillary tangles (HP:0002185) | 2.20756547 |
| 97 | Pigmentary retinal degeneration (HP:0001146) | 2.18869659 |
| 98 | Recurrent lower respiratory tract infections (HP:0002783) | 2.17637799 |
| 99 | Autoimmune hemolytic anemia (HP:0001890) | 2.16956868 |
| 100 | Alveolar cell carcinoma (HP:0006519) | 2.16703508 |
| 101 | Peritonitis (HP:0002586) | 2.16594800 |
| 102 | Amaurosis fugax (HP:0100576) | 2.15748448 |
| 103 | Amyloidosis (HP:0011034) | 2.14039729 |
| 104 | Glomerulopathy (HP:0100820) | 2.13299733 |
| 105 | Memory impairment (HP:0002354) | 2.11046053 |
| 106 | Abnormality of complement system (HP:0005339) | 2.10939216 |
| 107 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.10916991 |
| 108 | Acne (HP:0001061) | 2.10800879 |
| 109 | Increased IgE level (HP:0003212) | 2.10503925 |
| 110 | Keratoconjunctivitis sicca (HP:0001097) | 2.09352332 |
| 111 | IgA deficiency (HP:0002720) | 2.07965536 |
| 112 | Keratitis (HP:0000491) | 2.05912953 |
| 113 | Abnormality of the prostate (HP:0008775) | 2.05604039 |
| 114 | Congenital stationary night blindness (HP:0007642) | 2.04242326 |
| 115 | Porencephaly (HP:0002132) | 2.03993856 |
| 116 | Episodic fever (HP:0001954) | 2.03974845 |
| 117 | Cheilitis (HP:0100825) | 2.03916322 |
| 118 | Deep venous thrombosis (HP:0002625) | 2.03523089 |
| 119 | Purpura (HP:0000979) | 2.00226072 |
| 120 | Nasal polyposis (HP:0100582) | 1.99334088 |
| 121 | Abnormality of the nasal mucosa (HP:0000433) | 1.98612268 |
| 122 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98047198 |
| 123 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98047198 |
| 124 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98047198 |
| 125 | Apathy (HP:0000741) | 1.96843546 |
| 126 | Meningitis (HP:0001287) | 1.96682056 |
| 127 | Pathologic fracture (HP:0002756) | 1.96437869 |
| 128 | Spastic tetraparesis (HP:0001285) | 1.95153565 |
| 129 | Gastrointestinal infarctions (HP:0005244) | 1.94403193 |
| 130 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93268127 |
| 131 | Bone pain (HP:0002653) | 1.92595483 |
| 132 | Chronic diarrhea (HP:0002028) | 1.92352607 |
| 133 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.91633087 |
| 134 | Progressive visual loss (HP:0000529) | 1.91391232 |
| 135 | Abnormality of purine metabolism (HP:0004352) | 1.90459818 |
| 136 | Vascular calcification (HP:0004934) | 1.89923215 |
| 137 | Abnormality of the basal ganglia (HP:0002134) | 1.89082267 |
| 138 | Loss of speech (HP:0002371) | 1.87397706 |
| 139 | Spontaneous abortion (HP:0005268) | 1.85934815 |
| 140 | Leukocytosis (HP:0001974) | 1.85719981 |
| 141 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85483827 |
| 142 | Hepatosplenomegaly (HP:0001433) | 1.85346937 |
| 143 | Hypobetalipoproteinemia (HP:0003563) | 1.84922845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.88502224 |
| 2 | MAP3K14 | 4.59370453 |
| 3 | TYK2 | 3.93490566 |
| 4 | IKBKE | 3.86700286 |
| 5 | TBK1 | 3.74906728 |
| 6 | IRAK4 | 3.05876304 |
| 7 | FGFR4 | 2.81584742 |
| 8 | IRAK3 | 2.68694723 |
| 9 | JAK1 | 2.47429820 |
| 10 | KIT | 2.42717062 |
| 11 | JAK3 | 2.35363963 |
| 12 | EPHA3 | 2.32732543 |
| 13 | DDR2 | 2.29686869 |
| 14 | PIM2 | 2.17857628 |
| 15 | RIPK4 | 2.14319882 |
| 16 | SIK3 | 2.11772591 |
| 17 | MAP3K13 | 2.08109017 |
| 18 | IKBKB | 2.02975449 |
| 19 | ERN1 | 1.80212147 |
| 20 | IRAK1 | 1.77635779 |
| 21 | TXK | 1.51988806 |
| 22 | CHUK | 1.49921974 |
| 23 | BLK | 1.48697381 |
| 24 | TAOK3 | 1.47874509 |
| 25 | BMPR2 | 1.47731771 |
| 26 | NME2 | 1.46118521 |
| 27 | FGFR3 | 1.45449848 |
| 28 | MOS | 1.42592027 |
| 29 | PRPF4B | 1.30446679 |
| 30 | CDC42BPA | 1.27793868 |
| 31 | EIF2AK2 | 1.25395043 |
| 32 | IRAK2 | 1.20824951 |
| 33 | EPHB1 | 1.16612380 |
| 34 | BMPR1B | 1.14819888 |
| 35 | SIK1 | 1.14520759 |
| 36 | MST4 | 1.06184629 |
| 37 | TGFBR2 | 1.03976835 |
| 38 | CSK | 1.02483584 |
| 39 | SYK | 1.00621509 |
| 40 | TAOK1 | 0.98953102 |
| 41 | MAP3K11 | 0.97467833 |
| 42 | MST1R | 0.95914036 |
| 43 | MAP3K5 | 0.94052462 |
| 44 | RIPK1 | 0.90449881 |
| 45 | MAP3K3 | 0.87284704 |
| 46 | JAK2 | 0.87202593 |
| 47 | MATK | 0.85418002 |
| 48 | NEK9 | 0.82542569 |
| 49 | CASK | 0.82507330 |
| 50 | LYN | 0.82375012 |
| 51 | PIK3CG | 0.80388552 |
| 52 | ADRBK2 | 0.80035159 |
| 53 | HIPK2 | 0.78761357 |
| 54 | TYRO3 | 0.78551502 |
| 55 | ABL2 | 0.77002599 |
| 56 | FGR | 0.74880714 |
| 57 | HCK | 0.74292792 |
| 58 | MAP4K1 | 0.72254967 |
| 59 | LCK | 0.71229903 |
| 60 | BCR | 0.69679141 |
| 61 | BMX | 0.69671677 |
| 62 | NUAK1 | 0.69250173 |
| 63 | MARK3 | 0.69229260 |
| 64 | ERBB4 | 0.66510881 |
| 65 | LATS2 | 0.66349834 |
| 66 | INSRR | 0.65938204 |
| 67 | MAP3K1 | 0.65503263 |
| 68 | STK10 | 0.64581570 |
| 69 | CSF1R | 0.64485900 |
| 70 | GRK7 | 0.62105237 |
| 71 | PKN1 | 0.61200076 |
| 72 | DYRK3 | 0.58643656 |
| 73 | MAPK11 | 0.58495684 |
| 74 | PRKCD | 0.58366793 |
| 75 | CDK6 | 0.56179001 |
| 76 | ZAP70 | 0.55823695 |
| 77 | PRKCQ | 0.55521027 |
| 78 | ERBB3 | 0.55352007 |
| 79 | LATS1 | 0.55188641 |
| 80 | STK4 | 0.51780240 |
| 81 | PDGFRA | 0.48839552 |
| 82 | ABL1 | 0.47419202 |
| 83 | ARAF | 0.47227573 |
| 84 | DAPK2 | 0.45408989 |
| 85 | PIM1 | 0.44476326 |
| 86 | YES1 | 0.43372270 |
| 87 | FES | 0.41834110 |
| 88 | MAPK4 | 0.41458213 |
| 89 | DYRK1B | 0.41226999 |
| 90 | MAPK7 | 0.40697279 |
| 91 | MAP2K3 | 0.40427815 |
| 92 | AKT3 | 0.39396526 |
| 93 | NLK | 0.38290562 |
| 94 | EGFR | 0.38200490 |
| 95 | BTK | 0.38182497 |
| 96 | PRKCE | 0.37694296 |
| 97 | TEC | 0.37682220 |
| 98 | TAOK2 | 0.37162298 |
| 99 | CDK4 | 0.35942125 |
| 100 | FRK | 0.33973689 |
| 101 | RPS6KA5 | 0.33605381 |
| 102 | SGK2 | 0.33241874 |
| 103 | ZAK | 0.32822446 |
| 104 | DAPK3 | 0.32777157 |
| 105 | STK3 | 0.25204737 |
| 106 | SGK1 | 0.25174740 |
| 107 | ITK | 0.24929351 |
| 108 | BCKDK | 0.24445618 |
| 109 | TNK2 | 0.23436614 |
| 110 | ACVR1B | 0.23351540 |
| 111 | SGK3 | 0.22467975 |
| 112 | STK24 | 0.21309657 |
| 113 | PRKAA2 | 0.20995413 |
| 114 | INSR | 0.19747029 |
| 115 | CAMK2G | 0.19519468 |
| 116 | FER | 0.19304247 |
| 117 | IGF1R | 0.19168833 |
| 118 | CLK1 | 0.19100225 |
| 119 | GRK1 | 0.18786459 |
| 120 | TESK2 | 0.16624424 |
| 121 | PDK1 | 0.15426132 |
| 122 | MAPK3 | 0.15125514 |
| 123 | PRKCZ | 0.15021061 |
| 124 | PDGFRB | 0.14901912 |
| 125 | KDR | 0.14807377 |
| 126 | TRPM7 | 0.14488152 |
| 127 | MAP2K6 | 0.12186076 |
| 128 | CAMKK2 | 0.11167303 |
| 129 | MAPKAPK2 | 0.10439274 |
| 130 | FYN | 0.10285393 |
| 131 | PDPK1 | 0.08523636 |
| 132 | TRIB3 | 0.07766364 |
| 133 | CDK14 | 0.06859450 |
| 134 | CDK15 | 0.05896892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.60987387 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.05847395 |
| 3 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.89895490 |
| 4 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.81235830 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.63731365 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.49635932 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.33852984 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.31266478 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.25594155 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.16873559 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.02425825 |
| 12 | Influenza A_Homo sapiens_hsa05164 | 2.01370630 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99559279 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.99410291 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92102292 |
| 16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.87687653 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.85242646 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.71637758 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71008083 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.64790827 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64037413 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63296601 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62648317 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62155255 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.59292736 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54616407 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.54026803 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.53215929 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.52536779 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51590525 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.50554430 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.50477130 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46079471 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39117289 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.36486384 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25801259 |
| 37 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25365600 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09900002 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08394315 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08145220 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08053139 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06345611 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06174764 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.06071872 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.05081622 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97709421 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97243059 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96871258 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96213560 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92661479 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.91050604 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86699101 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.85040859 |
| 54 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84953358 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82424019 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81602055 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81126251 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.79910369 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.79437150 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79187192 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77683019 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77251502 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77219564 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 0.76324917 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75563807 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75065228 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.74949545 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72620403 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69234481 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68016539 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67228054 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66641530 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66038288 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66000459 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65722310 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63878199 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63299156 |
| 78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62725714 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62673986 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60149744 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58871030 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56597334 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56402116 |
| 84 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55289438 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.53489820 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51462726 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51283693 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.49877011 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48754650 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47399353 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45953788 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45422977 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44998052 |
| 94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.43992885 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.43307901 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41400299 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40933219 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39657843 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39178354 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38894335 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38185585 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34090480 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33385462 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32226668 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29626849 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29113472 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28563638 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28307364 |
| 109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27795234 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26874003 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.25587755 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.25519610 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.25145151 |
| 114 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24485602 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24387397 |
| 116 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23359164 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23254428 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23153528 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.21712356 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20308791 |
| 121 | Bile secretion_Homo sapiens_hsa04976 | 0.20307000 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.17018939 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16965412 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15425146 |
| 125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.13174065 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.12067643 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.06421400 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05376870 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.03810904 |
| 130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.01429175 |
| 131 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0532112 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | -0.0154100 |
| 133 | Platelet activation_Homo sapiens_hsa04611 | -0.0122052 |

